Published in Medical Letter on the CDC and FDA, January 8th, 2006
Emezine, a dissolving tablet placed between the lip and gum (also known as the buccal area), avoids the need for a patient to swallow a product during a period of nausea and, BDSI believes, offers a more patient-friendly alternative to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.